logo

Intercept Pharmaceuticals Inc. (ICPT)



Trade ICPT now with
  Date
  Headline
12/28/2017 4:05:52 PM Jefferies Is Lowering Intercept Pharmaceuticals Inc. (ICPT) FY18 Rev. Estimate To 187.8 M From 204.3 M
12/28/2017 4:05:34 PM Jefferies Is Lowering Intercept Pharmaceuticals Inc. (ICPT) FY17 Rev. Estimate To 131.2 M From 132.7 M
12/28/2017 4:04:53 PM Jefferies Is Raising Intercept Pharmaceuticals Inc. (ICPT) FY19 Estimate To -10.10 From -10.16
12/28/2017 4:04:32 PM Jefferies Is Cutting Intercept Pharmaceuticals Inc. (ICPT) FY18 Estimate To -12.98 From -12.38
12/28/2017 4:04:05 PM Jefferies Is Cutting Intercept Pharmaceuticals Inc. (ICPT) FY17 Estimate To -13.60 From -13.54
11/27/2017 7:05:51 AM Intercept Pharmaceuticals Appoints Christian Weyer As EVP, Research & Development
11/16/2017 4:09:33 PM Wedbush Reiterates Intercept Pharmaceuticals Inc. (ICPT) At Outperform With $253 Price Target
11/1/2017 2:49:52 PM Jefferies Is Increasing Intercept Pharmaceuticals Inc. (ICPT) FY18 Rev. Estimate To -11.84 M From -11.86 M
11/1/2017 2:49:30 PM Jefferies Is Cutting Intercept Pharmaceuticals Inc. (ICPT) FY17 Rev. Estimate To 132.7 M From 135.3 M
11/1/2017 2:49:02 PM Jefferies Is Raising Intercept Pharmaceuticals Inc. (ICPT) FY18 Estimate To -12.38 From -13.48
11/1/2017 2:48:42 PM Jefferies Is Increasing Intercept Pharmaceuticals Inc. (ICPT) FY17 Estimate To -13.54 From -14.25
11/1/2017 7:11:17 AM Intercept Pharma Q3 Loss Per Share $2.89 Vs Loss $3.59 Last Year
9/15/2017 9:49:34 AM Wedbush Reiterates Intercept Pharmaceuticals Inc. (ICPT) At Ourperform With $253 Price Target
8/25/2017 9:07:07 AM Wedbush Reiterates Intercept Pharmaceuticals Inc. (ICPT) At Outperform With $253 Price Target